SCHEMBL25963744

SCHEMBL25963744

C/C1=C(\C)c2ccccc2C(=O)Nc2ccccc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 3/20 0.63
▸ ACVR1 Q04771 2/20 0.63
▸ PDGFRA P16234 1/20 0.63
▸ FER P16591 1/20 0.63
▸ LTK P29376 1/20 0.63
▸ CDK8 P49336 1/20 0.63
▸ DYRK1B Q9Y463 1/20 0.63
▸ MAOA P21397 1/20 0.57
▸ MAOB P27338 1/20 0.57
▸ GSK3B P49841 1/20 0.56
▸ CSNK1G1 Q9HCP0 1/20 0.56
▸ ROS1 P08922 1/20 0.55
▸ CDK5 Q00535 1/20 0.55
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ POLB P06746 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ CASP3 P42574 1/20 0.48
▸ CASP2 P42575 1/20 0.48
▸ CASP7 P55210 1/20 0.48
▸ CASP6 P55212 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27425410 0.82 LRRK2 (0.74) LRRK2ACVR1PDGFRAFERLTK
SCHEMBL2420711 0.82 LRRK2 (0.90) LRRK2ACVR1PDGFRAFERLTK
SCHEMBL366728 0.82 — —
SCHEMBL11879510 0.82 ACVR1 (0.52) LRRK2ACVR1PDGFRAFERLTK
SCHEMBL27980501 0.78 LRRK2 (0.82) LRRK2ACVR1PDGFRAFERLTK
SCHEMBL1368292 0.78 LRRK2 (1.00) LRRK2ACVR1PDGFRAFERLTK
SCHEMBL16306322 0.77 ACVR1 (0.65) LRRK2ACVR1PDGFRAFERLTK
SCHEMBL9653269 0.77 ACVR1 (0.65) LRRK2ACVR1PDGFRAFERLTK
SCHEMBL8507659 0.76 CSNK1G1 (0.72) LRRK2ACVR1PDGFRAFERLTK
Hydrochloric Acid SCHEMBL6299954 0.76 LRRK2 (0.95) LRRK2ACVR1PDGFRAFERLTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3788032-B1 COMPOUNDS COMPRISING A LINKER FOR INCREASING TRANSCYCLOOCTENE STABILITY TAGWORKS PHARMACEUTICALS B V (NL) 2024-01-24 — — EP disclosed
WO-2023141856-A1 CD3-TARGETING MULTISPECIFIC ANTIBODY AND USE THEREOF 岩唐生物科技(杭州)有限责任公司 2023-08-03 — — WO disclosed
Send feedback